tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
SBFM
Sunshine Biopharma
RESEARCH TOOLSreports
Want to see SBFM full AI Analyst Report?

Sunshine Biopharma (SBFM) Ratios

427 Followers

Sunshine Biopharma Ratios

SBFM's free cash flow for Q4 2025 was $0.34. For the 2025 fiscal year, SBFM's free cash flow was decreased by $ and operating cash flow was $-0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Mar 23
Liquidity Ratios
Current Ratio
 4.17 4.17 4.11 4.48 3.94
Quick Ratio
 2.08 2.08 2.33 3.45 3.47
Cash Ratio
 1.42 1.42 1.53 2.93 3.15
Solvency Ratio
 -0.80 -0.80 -0.70 -0.71 -3.37
Operating Cash Flow Ratio
 -0.83 -0.83 -1.98 -1.58 -0.76
Short-Term Operating Cash Flow Coverage
 -24.72 -24.72 0.00 0.00 -42.66
Net Current Asset Value
$ 19.81M$ 19.81M$ 18.91M$ 18.75M$ 19.39M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.02 0.03
Debt-to-Equity Ratio
 0.04 0.04 0.04 0.03 0.04
Debt-to-Capital Ratio
 0.03 0.03 0.04 0.03 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.31 1.31 1.30 1.29 1.37
Debt Service Coverage Ratio
 -25.82 -19.33 -558.68 -30.73 -164.25
Interest Coverage Ratio
 0.00 0.00 -662.43 -34.85 -685.10
Debt to Market Cap
 0.05 0.04 0.00 0.00 0.01
Interest Debt Per Share
 0.20 0.20 1.37 65.35 106.02
Net Debt to EBITDA
 1.50 2.00 1.70 4.09 0.80
Profitability Margins
Gross Profit Margin
33.48%32.84%30.60%34.61%39.05%
EBIT Margin
-16.19%-12.34%-15.37%-16.49%-609.11%
EBITDA Margin
-15.28%-11.42%-14.73%-15.87%-608.54%
Operating Profit Margin
-12.34%-12.34%-16.67%-19.86%-621.28%
Pretax Profit Margin
-16.40%-16.40%-15.40%-17.06%-610.01%
Net Profit Margin
-16.46%-16.46%-14.72%-18.70%-615.37%
Continuous Operations Profit Margin
-16.46%-16.46%-14.72%-18.70%-615.37%
Net Income Per EBT
100.36%100.36%95.63%109.61%100.88%
EBT Per EBIT
132.93%132.93%92.38%85.91%98.19%
Return on Assets (ROA)
-19.86%-19.87%-16.80%-16.48%-90.52%
Return on Equity (ROE)
-24.99%-25.94%-21.85%-21.25%-123.66%
Return on Capital Employed (ROCE)
-18.95%-18.95%-23.97%-21.95%-119.40%
Return on Invested Capital (ROIC)
-18.78%-18.78%-22.73%-21.84%-118.75%
Return on Tangible Assets
-21.20%-21.20%-18.64%-17.40%-92.96%
Earnings Yield
-148.72%-116.86%-243.87%-68.21%-275.28%
Efficiency Ratios
Receivables Turnover
 10.49 10.49 9.02 9.44 2.27
Payables Turnover
 4.26 4.30 4.37 6.09 0.95
Inventory Turnover
 1.79 1.81 2.15 2.75 0.81
Fixed Asset Turnover
 27.17 27.17 23.53 23.79 3.76
Asset Turnover
 1.21 1.21 1.14 0.88 0.15
Working Capital Turnover Ratio
 1.74 1.81 1.79 1.21 0.39
Cash Conversion Cycle
 152.79 151.67 126.97 111.63 227.72
Days of Sales Outstanding
 34.78 34.78 40.49 38.67 160.59
Days of Inventory Outstanding
 203.62 201.67 170.07 132.87 453.31
Days of Payables Outstanding
 85.61 84.79 83.59 59.90 386.19
Operating Cycle
 238.41 236.46 210.56 171.53 613.91
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.28 -1.28 -17.86 -721.34 -691.48
Free Cash Flow Per Share
 -1.29 -1.32 -21.16 -786.12 -731.67
CapEx Per Share
 <0.01 0.04 3.31 64.78 40.18
Free Cash Flow to Operating Cash Flow
 1.00 1.03 1.19 1.09 1.06
Dividend Paid and CapEx Coverage Ratio
 -204.23 -30.55 -5.40 -11.13 -17.21
Capital Expenditure Coverage Ratio
 -204.23 -30.55 -5.40 -11.13 -17.21
Operating Cash Flow Coverage Ratio
 -6.56 -6.56 -13.16 -13.34 -6.86
Operating Cash Flow to Sales Ratio
 -0.15 -0.15 -0.36 -0.36 -1.21
Free Cash Flow Yield
-112.98%-107.67%-705.48%-144.77%-57.16%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.67 -0.86 -0.41 -1.47 -0.36
Price-to-Sales (P/S) Ratio
 0.13 0.14 0.06 0.27 2.24
Price-to-Book (P/B) Ratio
 0.17 0.22 0.09 0.31 0.45
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.89 -0.93 -0.14 -0.69 -1.75
Price-to-Operating Cash Flow Ratio
 -0.75 -0.96 -0.17 -0.75 -1.85
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.01 <0.01 0.02 <0.01
Price-to-Fair Value
 0.17 0.22 0.09 0.31 0.45
Enterprise Value Multiple
 0.64 0.77 1.29 2.36 0.43
Enterprise Value
 -3.57M -3.20M -6.63M -9.03M -11.35M
EV to EBITDA
 0.64 0.77 1.29 2.36 0.43
EV to Sales
 -0.10 -0.09 -0.19 -0.37 -2.61
EV to Free Cash Flow
 0.67 0.58 0.45 0.94 2.04
EV to Operating Cash Flow
 0.67 0.60 0.53 1.03 2.16
Tangible Book Value Per Share
 5.09 5.09 29.19 1.62K 2.75K
Shareholders’ Equity Per Share
 5.54 5.54 33.49 1.74K 2.85K
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 0.04 -0.10 >-0.01
Revenue Per Share
 8.73 8.73 49.70 1.98K 572.60
Net Income Per Share
 -1.44 -1.44 -7.32 -370.41 -3.52K
Tax Burden
 1.00 1.00 0.96 1.10 1.01
Interest Burden
 1.01 1.33 1.00 1.03 1.00
Research & Development to Revenue
 0.00 0.02 0.03 0.08 0.19
SG&A to Revenue
 0.54 0.54 0.43 0.42 2.05
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.89 0.89 2.44 1.95 0.20
Currency in USD